Varicella vaccine for prevention of chickenpox.
Release of varicella vaccine is anticipated in early 1995. The vaccine has proved to be safe and effective in clinical trials over the past 12 years. Proposed recommendations for use include a single dose for routine vaccination of 12 to 18-month-old infants and for catch-up immunization of children from 18 months to 12 years of age and a two dose schedule to immunize susceptible adolescents and adults.
Dennehy
P H
PH
Division of Pediatric Infectious Diseases, Rhode Island Hospital.
D000293:Adolescent; D000328:Adult; D002644:Chickenpox / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control*; D019433:Chickenpox Vaccine; D002648:Child; D002675:Child, Preschool; D017408:Guidelines as Topic; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology
D019433:Chickenpox Vaccine; D014765:Viral Vaccines